NADIM II: OS benefit of neoadjuvant nivolumab plus chemotherapy in NSCLC Presented ByDr Mariano Provencio, Hospital Universitario Puerta de Hierro-Majadahonda, Spain TrialPhase 2, NADIM II ConferenceWCLC 2022 23 August, 2022 10:52